GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » St Pharm Co Ltd (XKRX:237690) » Definitions » Loans Receivable

St Pharm Co (XKRX:237690) Loans Receivable : ₩0 Mil (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is St Pharm Co Loans Receivable?

St Pharm Co's Loans Receivable for the quarter that ended in Dec. 2024 was ₩0 Mil.


St Pharm Co Loans Receivable Historical Data

The historical data trend for St Pharm Co's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

St Pharm Co Loans Receivable Chart

St Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

St Pharm Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

St Pharm Co Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


St Pharm Co Loans Receivable Related Terms

Thank you for viewing the detailed overview of St Pharm Co's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


St Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
Teheran Road 78, Gangnam-gu, 7F MSA Building, Daechi-dong, Seoul, KOR, 891-43
St Pharm Co Ltd offers custom manufacturing services of Active pharmaceutical ingredients and their intermediates for their use in pharmaceutical development and be compliant to cGMP, requirements. The firm's business areas include commercial manufacturing of new drug development, manufacturing of generic active pharmaceutical ingredients, fine chemical's business and development of oligonucleotide therapeutics. The company's products comprise small molecule active pharmaceutical ingredients, Anti-cancer, Anti- coagulant active pharmaceutical ingredients, etc.

St Pharm Co Headlines

No Headlines